• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasoph

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Mar 5;S1201-9712(21)00210-1.
doi: 10.1016/j.ijid.2021.03.005. Online ahead of print.
Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs


Paolo Calistri[SUP] 1 [/SUP], Laura Amato[SUP] 2 [/SUP], Ilaria Puglia[SUP] 2 [/SUP], Francesca Cito[SUP] 2 [/SUP], Alessandra Di Giuseppe[SUP] 2 [/SUP], Maria Luisa Danzetta[SUP] 2 [/SUP], Daniela Morelli[SUP] 2 [/SUP], Marco Di Domenico[SUP] 2 [/SUP], Marialuigia Caporale[SUP] 2 [/SUP], Silvia Scialabba[SUP] 2 [/SUP], Ottavio Portanti[SUP] 2 [/SUP], Valentina Curini[SUP] 2 [/SUP], Fabrizia Perletta[SUP] 2 [/SUP], Cesare Camm?[SUP] 2 [/SUP], Massimo Ancora[SUP] 2 [/SUP], Giovanni Savini[SUP] 2 [/SUP], Giacomo Migliorati[SUP] 2 [/SUP], Nicola D'Alterio[SUP] 2 [/SUP], Alessio Lorusso[SUP] 2 [/SUP]



Affiliations

Abstract

Following the announcement on December 2020 about the emergence of a new variant (VOC 202012/01, B.1.1.7 lineage) in the United Kingdom a targeted surveillance was put in place in Abruzzo region (Italy), which allowed to detect 313 persons affected by lineage B.1.1.7, up to the 20[SUP]th[/SUP] of February 2021. We investigated the results of RT-PCR on nasopharyngeal swabs tested from December 2020 to February 2021, to verify any difference on the viral load and persistence between people infected by lineage B.1.1.7 and others. Statistically significant lower values of C[SUB]T[/SUB] associated with the detection of the N protein encoding gene (C[SUB]T[/SUB] N) were observed in persons with lineage B.1.1.7 infection (median C[SUB]T[/SUB] N = 15.8) in comparison to those infected by other lineages (median C[SUB]T[/SUB] N = 16.9). A significant longer duration of the persistence of SARS-CoV-2 RNA in nasopharyngeal swabs was observed in persons with lineage B.1.1.7 infection (16 days) in comparison to those infected by other lineages (14 days).

Keywords: Abruzzo; Italy; SARS-CoV-2; VOC 202012/01; coronavirus; lineage B.1.1.7.
 
Back
Top Bottom